Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Urine biomarkers in bladder cancer—current status and future perspectives
Urine markers to detect bladder cancer have been the subject of research for decades. The
idea that urine—being in continuous contact with tumour tissue—should provide a vector of …
idea that urine—being in continuous contact with tumour tissue—should provide a vector of …
[HTML][HTML] Molecular markers for bladder cancer screening: an insight into bladder cancer and FDA-approved biomarkers
Bladder cancer is one of the most financially burdensome cancers globally, from its
diagnostic to its terminal stages. The impact it imposes on patients and the medical …
diagnostic to its terminal stages. The impact it imposes on patients and the medical …
Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy
Current non-invasive approaches for detection of urothelial cancers are suboptimal. We
developed a test to detect urothelial neoplasms using DNA recovered from cells shed into …
developed a test to detect urothelial neoplasms using DNA recovered from cells shed into …
Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers
This is the first of 2 articles that summarize the findings of the International Consensus Panel
on cytology and bladder tumor markers. The objectives of our panel were to reach a …
on cytology and bladder tumor markers. The objectives of our panel were to reach a …
[PDF][PDF] Systematic review of the clinical and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the …
Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic
diagnosis and urine biomarkers (FISH, Imm Page 1 Health Technology Assessment 2010; Vol …
diagnosis and urine biomarkers (FISH, Imm Page 1 Health Technology Assessment 2010; Vol …
Molecular markers for bladder cancer screening, early diagnosis, and surveillance: the WHO/ICUD consensus
Due to the lack of disease-specific symptoms, diagnosis and follow-up of bladder cancer has
remained a challenge to the urologic community. Cystoscopy, commonly accepted as a gold …
remained a challenge to the urologic community. Cystoscopy, commonly accepted as a gold …
A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures
METHODS: Bile duct brushing and aspirate specimens were collected from 131 patients
being evaluated for possible malignant bile duct strictures. Both specimen types were …
being evaluated for possible malignant bile duct strictures. Both specimen types were …
UroVysion FISH test for detecting urothelial cancers: meta-analysis of diagnostic accuracy and comparison with urinary cytology testing
T Hajdinjak - Urologic oncology: seminars and original …, 2008 - Elsevier
OBJECTIVES: Since the introduction of the UroVysion test for detecting urothelial cancers in
urine, its reported performance has varied. This article systematically analyzed reported …
urine, its reported performance has varied. This article systematically analyzed reported …
Evaluation of urovysion and cytology for bladder cancer detection: a study of 1835 paired urine samples with clinical and histologic correlation
H Dimashkieh, DJ Wolff, TM Smith… - Cancer …, 2013 - Wiley Online Library
BACKGROUND Urine cytology has been used for screening of bladder cancer but has been
limited by its low sensitivity. UroVysion is a multiprobe fluorescence in situ hybridization …
limited by its low sensitivity. UroVysion is a multiprobe fluorescence in situ hybridization …
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers
Abstract Background: Updated National Academy of Clinical Biochemistry Laboratory
Medicine Practice Guidelines for the use of tumor markers in the clinic have been …
Medicine Practice Guidelines for the use of tumor markers in the clinic have been …